I-Mab
Anti-IFNAR1 antibodies for treating autoimmune diseases

Last updated:

Abstract:

Provided are antibodies or fragments thereof having binding specificity to the human interferon alpha and beta receptor subunit 1 (IFNAR1) protein. In various examples, the antibodies or fragments thereof include a VH and VL CDRs as provided, or variants thereof. Methods of using the antibodies or fragments thereof for treating autoimmune diseases and disorders are also provided.

Status:
Grant
Type:

Utility

Filling date:

18 Sep 2019

Issue date:

13 Jul 2021